Valuation: LeMaitre Vascular, Inc.

Market Cap 2.32B 2.01B 1.87B 1.72B 3.25B 221B 3.3B 22.08B 8.67B 110B 8.7B 8.5B 369B P/E 2026 *
33.8x
P/E 2027 * 31.1x
Enterprise Value 2.06B 1.79B 1.67B 1.53B 2.9B 197B 2.94B 19.69B 7.73B 98.09B 7.75B 7.58B 329B EV / Sales 2026 *
7.37x
EV / Sales 2027 * 6.54x
Free-Float
87.27%
Yield 2026 *
0.99%
Yield 2027 * 1.11%
1 day-1.67%
1 week+4.12%
1 month+5.99%
3 months-2.75%
6 months+27.34%
Current year+26.43%
1 week 85.5
Extreme 85.5
90
1 month 85
Extreme 85
92
Current year 68
Extreme 68
99
1 year 68
Extreme 68
99
3 years 42
Extreme 42
102
5 years 35.4
Extreme 35.4
102
10 years 19.1
Extreme 19.1
102
Manager TitleAgeSince
Chief Executive Officer 61 1992-05-31
Director of Finance/CFO 51 2025-03-09
Director of Finance/CFO 62 1999-12-31
Director TitleAgeSince
Director/Board Member 68 2002-12-31
Chairman 61 2003-12-31
Director/Board Member 61 2016-10-23
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%+4.12% - - 2.32B
-0.43%+1.06%+24.03%+5.21% 212B
-0.61%+1.82%-1.07%-23.54% 137B
+0.10%+4.69%-26.86%+9.07% 125B
+1.59%+5.60%-55.67%-9.94% 69.46B
-0.98%+4.16%+8.50%+4.90% 49.56B
-0.91%+5.13%-20.61%-29.50% 47.2B
-0.25%-0.14%+21.91%+12.97% 39.08B
-0.79%+0.70%+29.97%+37.50% 37.05B
+0.00%+5.67%+116.67%+8.35% 30.97B
Average -0.39%+3.14%+10.76%+1.67% 83.06B
Weighted average by Cap. -0.25%+2.77%+3.70%-0.90%

Financials

2026 *2027 *
Net sales 280M 243M 227M 208M 393M 26.73B 399M 2.67B 1.05B 13.31B 1.05B 1.03B 44.62B 306M 266M 247M 227M 429M 29.19B 436M 2.92B 1.14B 14.53B 1.15B 1.12B 48.72B
Net income 69.28M 60.22M 56.05M 51.46M 97.19M 6.61B 98.69M 661M 259M 3.29B 260M 254M 11.04B 75.98M 66.05M 61.47M 56.44M 107M 7.25B 108M 725M 284M 3.61B 285M 279M 12.11B
Net Debt -251M -218M -203M -187M -352M -23.98B -358M -2.4B -940M -11.94B -943M -923M -40.03B -314M -273M -254M -233M -441M -29.98B -447M -3B -1.18B -14.93B -1.18B -1.15B -50.05B
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change
26-07-31 €88.50 -1.67%
26-07-30 €90.00 +1.12%
26-07-29 €89.00 +2.89%
26-07-28 €86.50 +1.17%
26-07-27 €85.50 +0.59%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
101.32USD
Average target price
118.75USD
Spread / Average Target
+17.20%

Quarterly revenue - Rate of surprise